Cardiovascular actions of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) a new alpha-adrenergic receptor antagonist.
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D002264:Carboxylic Acids / Q000494:pharmacology; D003326:Coronary Circulation / Q000187:drug effects; D004285:Dogs; D004347:Drug Interactions; D004562:Electrocardiography; D004837:Epinephrine / Q000494:pharmacology; D005019:Ethyl Ethers / Q000494:pharmacology; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D007545:Isoproterenol / Q000494:pharmacology; D008026:Ligation; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects; D009638:Norepinephrine / Q000494:pharmacology; D011804:Quinolines / Q000494:pharmacology*; D013565:Sympatholytics / Q000494:pharmacology*
D000317:Adrenergic alpha-Antagonists; D002264:Carboxylic Acids; D005019:Ethyl Ethers; D011804:Quinolines; D013565:Sympatholytics; C000470:EEDQ; D007545:Isoproterenol; D009638:Norepinephrine; D004837:Epinephrine